๐Ÿง 
Atlanta Perinatal Associates  ยท  Maternal-Fetal Medicine

Multiple Sclerosis
& Pregnancy

Preconception Counseling โ€” A Partnership for Your Healthiest Pregnancy

Use โ† โ†’ arrow keys or the buttons below to navigate

Overview

What We Will Cover Today

๐ŸŒฑ
Fertility
MS does not impair your ability to conceive
โš–๏ธ
Medications
Safe transitions before and during pregnancy
๐Ÿ“…
Timing
Optimizing disease stability before conception
๐Ÿ‘ถ
Postpartum
Protecting you after delivery
Fertility & Genetics

Good News About Fertility & Genetics

โœ“
MS does not impair fertility or ovarian reserve
2โ€“3.5%
Child's risk of MS with one affected parent
~20%
Risk only if both parents are affected

IVF is generally safe. Certain GnRH protocols may carry a small relapse risk โ€” we will review your specific plan.

Disease Stability

The Ideal Window for Conception

๐Ÿฉบ
Now
Review disease activity & MRI
๐Ÿ’Š
Months 1โ€“3
Transition medications safely
๐Ÿ“‹
Month 6โ€“12
Confirm clinical & MRI stability
๐ŸŒธ
Conception
Attempt pregnancy when stable

Goal: At least 6โ€“12 months of stability before stopping high-efficacy therapies.

Medication Safety

Understanding Your Medication Options

๐ŸŸข
Generally Safe
Injectable platform therapies may be continued
๐ŸŸก
Requires Planning
High-efficacy monoclonals โ€” timing & monitoring needed
๐Ÿ”ด
Must Stop Before Pregnancy
Oral agents & teratogens โ€” washout required

Every plan is individualized. We balance relapse risk against fetal safety.

Medication Guide

Your Medication Safety Reference

Medication Status Key Action
Glatiramer acetate / Interferon-ฮฒ โœ“ Safe May continue through conception
Natalizumab โš  Plan May continue into 2nd/3rd trimester in high-risk patients
Ocrelizumab / Rituximab โš  Plan Contraception 6โ€“12 months after last dose; monitor infant B-cells
Fingolimod / Siponimod โœ— Stop 2-month washout required; rebound risk if stopped abruptly
Teriflunomide โœ— Stop Accelerated elimination required; confirm plasma level <0.02 mg/L
Cladribine / Alemtuzumab โœ“ Complete First Complete treatment 4โ€“6 months before conception; no further dosing needed
During Pregnancy

What to Expect During Pregnancy

๐Ÿ“‰
Relapse Rate Decreases
Especially in the 3rd trimester โ€” pregnancy has a natural protective effect
๐Ÿค
Multidisciplinary Care
Your neurologist and MFM team will coordinate your care throughout pregnancy
๐ŸŒฟ
Folic Acid
Start 5 mg daily at least 3 months before conception
Labor & Delivery

Labor & Delivery โ€” What You Should Know

Postpartum

The Postpartum Period โ€” Our Priority

โ†‘
Relapse risk is highest in the first 3 months postpartum
๐Ÿคฑ
Breastfeeding may offer modest protection against early relapses
๐Ÿ’Š
We will plan prompt resumption of your DMT after delivery

High-risk patients may benefit from IVIG or early DMT restart. We will individualize your postpartum plan.

Breastfeeding

Breastfeeding & Medications

Medication Breastfeeding
Glatiramer acetate / Interferon-ฮฒ โœ“ Compatible โ€” large molecules, low infant absorption
Ocrelizumab / Rituximab โš  Limited Data โ€” breast milk levels very low; discuss with your team
Fingolimod / Teriflunomide โœ— Avoid โ€” small molecules may transfer into breast milk

Breastfeeding is encouraged. We will select a medication compatible with nursing whenever possible.

Next Steps

Your Preconception Action Plan

๐Ÿค
Atlanta Perinatal Associates

You Are Not Alone in This Journey

MS and a healthy pregnancy are not mutually exclusive. With careful planning and a dedicated team, most patients with MS have excellent pregnancy outcomes.

ACOG Practice Bulletin  ยท  SMFM Guidelines  ยท  ECTRIMS/EAN Recommendations
Content reviewed for guideline consistency. Slides support physician-led counseling.

← OpenMFM Library